Key result
Angiographic assessment of tumor vascularity identified 40% of histologic responders and 91% of nonresponders after two courses of chemotherapy, and 91% and 50% respectively after a median of four.
Why the study?
Does angiographic assessment of tumor vascularity accurately identify histologic response to preoperative chemotherapy in patients with high-grade osteosarcoma?
Observational (n=81)
Does angiographic assessment of tumor vascularity accurately identify histologic response to preoperative chemotherapy in patients with high-grade osteosarcoma?
Angiographic assessment of tumor vascularity provides a useful guideline for determining preoperative chemotherapy strategy in osteosarcoma.
Answers are grounded in this paper and cite their sources.
May support response-adapted chemotherapy in osteosarcoma; leaves open prospective validation against histologic and survival endpoints.
Adjuvant chemotherapy prolongs the survival of patients with high-grade osteosarcoma. Preoperative chemotherapy allows identification of effective agents for adjuvant chemotherapy based on response of the primary tumor. Preoperative determination of tumor response has therapeutic implications, and angiography offers a less subjective means of assessing it than do conventional radiography or computed tomography. Changes in tumor vascularity, as seen angiographically, after two courses and at the time of the last of several courses of preoperative chemotherapy were correlated with histologic tumor necrosis of resected specimens in 81 patients. Angiographically, 40% of the histologic responders and 91% of the nonresponders were identified after two courses of preoperative chemotherapy. After a median of four courses of chemotherapy, 91% of the responders but only 50% of the nonresponders were identified angiographically. Angiographic assessment of tumor vascularity, although not of absolute value, offers a useful guideline for determining the preoperative chemotherapy strategy.
No takes yet. Share an insight, caveat, or question.
Carrasco et al. (1989) conducted an observational in Osteosarcoma (n=81). Angiographic assessment of tumor vascularity vs. Histologic tumor necrosis was evaluated on Identification of histologic responders and nonresponders. Angiographic assessment of tumor vascularity identified 40% of histologic responders and 91% of nonresponders after two courses of chemotherapy, and 91% and 50% respectively after a median of four.
Synapse has enriched 10 related papers. Consider them for comparative context: